Nippon Kayaku Co., Ltd.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1916-06-05
- Employees
- 5.9K
- Market Cap
- -
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Nippon Kayaku Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT00530075
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Sweden
🇳🇱University Hospital Maastricht, Maastricht, Netherlands
🇬🇧Addenbrookes Hospital, Cambridge, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath